An injection that can prevent HIV infection for six months has been approved by the US Food and Drug Administration (FDA).

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

The agency has granted approvals steadily in the first part of the year, including nods for several breakthrough therapies.

Shares of Gilead Sciences Inc. (GILD) jumped more than 2% on Friday afternoon after the U.S. Supreme Court upheld a part of ...

The Supreme Court on Friday granted the HIV-prevention field a historic win — yet with a major caveat — as it upheld a ...

The Supreme Court upheld free preventive care, rejecting a challenge that threatened coverage for STI testing, cancer ...

Labcorp (LH), and Gilead (GILD) rise as Supreme Court upholds right to free preventive care under Obamacare. Read more here.

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.